Previous studies have shown that the PI3K/AKT/mTOR signalling pathway plays a key role in the survival and growth of tumour cells, so it might become an ideal intervention target for cancer treatment [27], resulting in the birth of many small molecule targeted drugs. This evidence concerns the gene PIK3CB and neoplasm.